Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naive, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC) Meeting Abstract
| Authors: | Msaouel, P.; Siefker-Radtke, A. O.; Sweis, R.; Mao, S.; Rosenberg, J. E.; Vaishampayan, U. N.; Rezazadeh Kalebasty, A.; Pili, R.; Bupathi, M.; Nordquist, L. T.; Shaffer, D. R.; Davis, N.; Zhang, T.; Gandhi, S.; Christensen, J.; Shazer, R.; Yan, X.; Winter, M.; Der-Torossian, H.; Vasudeva Iyer, G. |
| Abstract Title: | Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naive, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC) |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S556 |
| Language: | English |
| ACCESSION: | WOS:000573469100701 |
| DOI: | 10.1016/j.annonc.2020.08.777 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 705MO -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
